SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-20-011842
Filing Date
2020-11-04
Accepted
2020-11-04 17:00:54
Documents
2
Period of Report
2020-11-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT gtbp_8k.htm 8-K 28019
2 FORM OF FIRST AMENDMENT AND EXTENSION OF STANDSTILL AND FORBEARANCE AGREEMENT gtbp_ex101.htm EX-99.1 16695
  Complete submission text file 0001654954-20-011842.txt   46153
Mailing Address 9350 WILSHIRE BLVD. SUITE 203 BEVERLY HILLS CA 90212
Business Address 9350 WILSHIRE BLVD. SUITE 203 BEVERLY HILLS CA 90212 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-08092 | Film No.: 201287432
SIC: 2834 Pharmaceutical Preparations